Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?

Hellwig, Thaddaus; Gulseth, Michael

doi:10.1177/1060028013504741

Public

Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?

Shared by NobleBlocks on Nov 1, 2013 • 12:00 AM UTC

Authors:

Thaddaus Hellwig

Michael Gulseth

Abstract

OBJECTIVE: To review pharmacokinetic and pharmacodynamic drug-drug interactions (DDIs) involving new oral anticoagulants for atrial fibrillation. DATA SOURCES: A literature search was conducted via PubMed and the Cochrane database to identify DDI studies using the terms drug interactions, dabigatran...

Subject

anticoagulants

atrial fibrillation

drug-drug interactions

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!